Schwebke, Jane R

Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines

Nyirjesy, P., Brookhart, C., Lazenby, G., Schwebke, J., & Sobel, J. D. (2022) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 149

Identification of key bacteria involved in the induction of incident bacterial vaginosis: a prospective study.

Muzny, C. A., Blanchard, E., Taylor, C. M., Aaron, K. J., Talluri, R., Griswold, M. E., Redden, D. T., Luo, M., Welsh, D. A., Van Der Pol, W. J., et al. (2018) · The Journal of Infectious Diseases

Reproductive tract infections researchGut microbiota and health

Cited by 145

Clinical Validation of a Test for the Diagnosis of Vaginitis

Gaydos, C. A., Beqaj, S., Schwebke, J. R., Lebed, J., Smith, B., Davis, T. E., Fife, K. H., Nyirjesy, P., Spurrell, T., Furgerson, D., et al. (2017) · Obstetrics & Gynecology

Reproductive tract infections researchBacterial Identification and Susceptibility Testing

Cited by 144

Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial

Marrazzo, J. M., Dombrowski, J. C., Wierzbicki, M. R., Perlowski, C., Pontius, A., Dithmer, D., & Schwebke, J. (2019) · Clinical Infectious Diseases

Reproductive tract infections researchUrinary Tract Infections Management

Cited by 89

Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303)

Schwebke, J. R., Sobel, R., Gersten, J. K., Sussman, S. A., Lederman, S. N., Jacobs, M. A., Chappell, B. T., Weinstein, D. L., Moffett, A. H., Azie, N. E., et al. (2022) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityReproductive tract infections research

Cited by 82

Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.

Muzny, C. A., Blackburn, R. J., Sinsky, R. J., Austin, E. L., & Schwebke, J. R. (2014) · Clinical Infectious Diseases

Reproductive tract infections researchCervical Cancer and HPV Research

Cited by 60

A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women.

Schwebke, J. R., & Desmond, R. A. (2010) · Sexually Transmitted Diseases

Reproductive tract infections researchHIV/AIDS Research and Interventions

Cited by 57

The clinical spectrum of Trichomonas vaginalis infection and challenges to management

Muzny, C. A., & Schwebke, J. R. (2013) · Sexually Transmitted Infections

Reproductive tract infections researchUrinary Tract Infections Management

Cited by 53

Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with women.

Muzny, C. A., Lensing, S. Y., Aaron, K. J., & Schwebke, J. R. (2019) · Sexually Transmitted Infections

Reproductive tract infections researchCervical Cancer and HPV Research

Cited by 43

Comparisons of vaginal flora patterns among sexual behaviour groups of women: implications for the pathogenesis of bacterial vaginosis.

Olson, K. M., Boohaker, L. J., Schwebke, J. R., Aslibekyan, S., & Muzny, C. A. (2018) · Sexual Health

Reproductive tract infections researchCervical Cancer and HPV Research

Cited by 25

Genotypic characterization of Trichomonas vaginalis isolates among women who have sex with women in sexual partnerships.

Muzny, C. A., Rivers, C. A., Mena, L. A., & Schwebke, J. R. (2012) · Sexually Transmitted Diseases

Reproductive tract infections researchCervical Cancer and HPV Research

Cited by 18